Sign in

CIK 0001725160

  • Non-accelerated filer
  • Smaller reporting company

Zentalis Pharmaceuticals, Inc.

Sign in to watch
Ticker
ZNTL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
823607803
Phone
+1 858-263-4333
Business address
10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
Former names
Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 24 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-02-14 Pinto Alexis Chief Legal Officer Sale −614 $50.16 $31K 22,317
2022-02-14 Pinto Alexis Chief Legal Officer Sale −77 $50.75 $4K 22,240
2022-02-14 Gallagher Cam Director Sale −2,079 $50.16 $104K 400,922
2022-02-14 Gallagher Cam Director Sale −259 $50.75 $13K 400,663
2022-02-14 Gallagher Cam Director Sale −4,850 $50.17 $243K 395,813
2022-02-14 SUN ANTHONY Y President & CEO Sale −4,208 $50.16 $211K 1,217,998
2022-02-14 SUN ANTHONY Y President & CEO Sale −525 $50.75 $27K 1,217,473
2022-02-10 Bunker Kevin D. Chief Operating Officer Grant or award +22,481 768,798
2022-02-10 Bunker Kevin D. Chief Operating Officer Sale −2,366 $52.15 $123K 177,634
2022-02-10 Bunker Kevin D. Chief Operating Officer Sale −3,074 $53.19 $164K 174,560
2022-02-10 Bunker Kevin D. Chief Operating Officer Sale −3,321 $54.20 $180K 171,239
2022-02-10 Bunker Kevin D. Chief Operating Officer Sale −1,239 $54.96 $68K 170,000
2022-02-10 Bunker Kevin D. Chief Operating Officer Grant or award · Stock Option (Right to Buy) +52,745 52,745
2022-02-10 Voliotis Dimitris SVP, Clinical Development Grant or award +10,329 16,579
2022-02-10 Voliotis Dimitris SVP, Clinical Development Grant or award · Stock Option (Right to Buy) +24,234 24,234
2022-02-10 Pinto Alexis Chief Legal Officer Grant or award +16,405 22,931
2022-02-10 Pinto Alexis Chief Legal Officer Grant or award · Stock Option (Right to Buy) +38,489 38,489
2022-02-10 Epperly Melissa B, Chief Financial Officer Grant or award +16,405 266,407
2022-02-10 Epperly Melissa B, Chief Financial Officer Grant or award · Stock Option (Right to Buy) +38,489 38,489
2022-02-10 Gallagher Cam Director Grant or award +8,203 395,406

Page 11 of 28 · 545 trades